You must have heard the catchphrase “Yeh meri expertise nahi hai, toh I am out.” from Shark Tank India, but do you know the story of the woman behind it?
Her name is synonymous with success and inspiration in the Indian pharma industry. Known for her role as the Executive Director of Emcure Pharmaceuticals and as a ‘shark’ on Shark Tank India multiple times, Namita Thapar has carved a niche for herself in both the pharmaceutical industry and the startup world. She is a role model for aspiring entrepreneurs everywhere.
Early Life and Background
Born on 21st March 1977, in Pune, Maharashtra, Namita Thapar was raised in a family that valued education and business instinct. Her father, Satish Mehta, is the founder of Emcure Pharmaceuticals, which has grown to become one of India’s leading pharmaceutical firms. Namita’s education and being in a business-oriented environment sowed the seeds of entrepreneurship early on.
Namita pursued Chartered Accountancy (CA) from the Institute of Chartered Accountants of India (ICAI) at just 21 years of age. She then went on to complete her Masters in Business Administration (MBA) from Duke University’s Fuqua School of Business.
Her Journey as an Entrepreneur
Namita Thapar began her career in the United States of America, where she worked for Guidant Corporation, a medical device company, as a Business Finance Lead. After six years of gaining experience in financial planning and management, she returned to India in 2007 to join her father’s company, Emcure Pharmaceuticals.
Starting as the Chief Financial Officer (CFO), Namita quickly made her mark, managing several portfolios, including finance, Information Technology (IT), and Human Resources (HR). Over time, she took charge of Emcure’s Indian operations. Today, Emcure operates in over 70 countries and generates an annual revenue of $750 million and employs over 10,000 people.
Namita also started Incredible Ventures Ltd in 2017, an educational company that promotes entrepreneurship among young students aged 11-18 years. This company has a presence in Mumbai, Delhi, Bengaluru, Pune, Chennai and Ahmedabad, and is a proof of her commitment to train young minds.
Her Journey in Shark Tank India
Namita Thapar gained fame through her role as an investor on Shark Tank India. With her catchphrase, “Yeh meri expertise nahi hai, toh I am out” she became a fan favourite for her candidness and strategic investment decisions. Over the three seasons, she has invested in over 25 startups, including Bummer, Altor, InACan and Wakao Foods.
Her Companies
Namita’s influence is beyond Emcure Pharmaceuticals and Shark Tank India. As an advocate for entrepreneurship, she has launched several initiatives, including Incredible Ventures Ltd, to educate the younger generation. She is also a board member of Finolex Cables and the Fuqua School of Business India Regional Advisory Board.
Start investing in Index Funds.
Net Worth and Investments
Namita Thapar’s estimated net worth is around ₹600 crore. The majority of her wealth comes from her role at Emcure Pharmaceuticals, which has a net worth of over ₹6,000 crore. She also owns a mansion in Pune which is worth ₹50 crore.
She has made many personal investments, especially in healthcare and technology. Some of these investments include:
| Date | Organisation | Funding Round | Money Raised |
|---|---|---|---|
| 16th April 2024 | Medulance | Series A | $3 million |
| 1st March 2024 | Pragmatech Healthcare Solutions | Angel Round | ₹7.5 million |
| 20th February 2024 | Chefling | Angel Round | ₹4 million |
| 12th March 2023 | SoulUp | Angel Round | ₹50 million |
| 3rd February 2022 | The Renal Project | Seed Round | ₹5 million |
Wrapping Up
From excelling academically to leading Emcure Pharmaceuticals, and now as a prominent face in the startup community through Shark Tank India, she continues to inspire millions of young entrepreneurs.
Plus, she has played an important role in shaping the pharmaceutical industry in India. She even actively partners with government initiatives like NITI Aayog’s Women Entrepreneurship Platform and the Digital Health Task Force. Her contributions to healthcare, business education and social initiatives make her a true change-maker in India’s corporate world.
FAQs
Who is Namita Thapar?
Namita Thapar is the Executive Director of Emcure Pharmaceuticals and a shark on the television show ‘Shark Tank India’.
What is Namita Thapar’s net worth?
Namita Thapar’s net worth is estimated to be around ₹600 crore.
What is Namita Thapar’s educational background?
Namita Thapar is a Chartered Accountant from ICAI and holds a Masters in Business Administration from Duke University’s Fuqua School of Business.
How did Namita Thapar start her career?
Namita began her career in the United States of America with Guidant Corporation before joining her family’s business, Emcure Pharmaceuticals, in 2007.
Which companies have Namita Thapar invested in through Shark Tank India?
Namita has invested in over 25 startups, including Bummer, Altor, InACan, Wakao Foods and more.
What is Emcure Pharmaceuticals?
Emcure Pharmaceuticals is a pharmaceutical company in India. It was founded by Namita’s father, Satish Ramanlal Mehta, in 1981.
Interested in how we think about the markets?
Read more: Zen And The Art Of Investing
Watch here: The Legacy of Ratan Tata: A Timeline of His Achievements
Start investing through a platform that brings goal planning and investing to your fingertips. Visit kuvera.in to discover Direct Plans of Mutual Funds and Fixed Deposits and start investing today.
AREVUK Advisory Services Pvt Ltd | SEBI Registration No. INA200005166
DISCLAIMER: Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. The securities quoted are for illustration only and are not recommendatory.
